T1	Participants 86 106	diffuse lung disease
T2	Participants 565 618	patients with diffuse parenchymal lung disease (DPLD)
T3	Participants 668 717	95 patients who underwent fluoroscopy guided TBLB
T4	Participants 742 822	Patients with a lung mass or solitary lung nodule undergoing TBLB were excluded.
T5	Participants 2080 2113	diffuse infiltrative lung disease
